Analysis of drug-drug interactions in elderly patients with multiple comorbidities.

Project Abstract

This research project aims to investigate the prevalence and implications of drug-drug interactions (DDIs) in elderly patients with multiple comorbidities. With the increasing aging population and the rise in the number of individuals managing multiple chronic conditions, the risk of DDIs has become a significant concern in healthcare. The study will focus on understanding the patterns, risk factors, and clinical outcomes associated with DDIs in this vulnerable patient population. The research will adopt a mixed-methods approach, combining quantitative analysis of medical records and prescription data with qualitative interviews with healthcare providers and elderly patients themselves. By examining the prescription patterns and medication histories of elderly patients with multiple comorbidities, the study aims to identify common DDIs, assess their clinical impact, and explore potential strategies for prevention and management. The literature review will provide a comprehensive overview of existing research on DDIs in elderly patients, highlighting the gaps in current knowledge and underscoring the importance of tailored interventions to mitigate the risks associated with polypharmacy. The research methodology will outline the data collection methods, sampling strategy, and analytical techniques employed to achieve the study objectives. The findings from this study are expected to shed light on the complex interplay between age-related physiological changes, polypharmacy, and comorbidities that contribute to the heightened risk of DDIs in elderly patients. Through a detailed analysis of medication regimens, potential drug interactions, and clinical outcomes, the research will offer insights into optimizing medication management practices and enhancing patient safety in this vulnerable population. The implications of this research extend beyond academic discourse, as the findings will inform healthcare providers, policymakers, and pharmaceutical companies about the critical need for individualized medication therapy in elderly patients with multiple comorbidities. By raising awareness of the risks associated with DDIs and promoting interdisciplinary collaboration in medication management, this study aims to contribute to improved health outcomes and quality of life for elderly patients. In conclusion, this research project on the analysis of drug-drug interactions in elderly patients with multiple comorbidities represents a critical step towards enhancing the safety and effectiveness of pharmacotherapy in this vulnerable population. By bridging the gap between research and clinical practice, the study strives to empower healthcare professionals with evidence-based insights to optimize medication management and improve patient care for elderly individuals with complex health needs.

Project Overview